CClinicalTrials.gg
CompletedNCT05259891CAPTUREUpdated May 16, 2023

eegCap Application in Paediatrics wiTh redUced GCS in REsus

An observational study in Status Epilepticus, Altered Level of Consciousness and Non-epileptic Seizures, sponsored by University College Cork. Completed at 1 site in Ireland. Open to participants aged 0 Months to 176 Months. Per ClinicalTrials.gov, last updated 2023-05-16.

Sponsored by University College Cork · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
0 Months to 176 Months
Sex
All
01

Study summary

Children frequently present with altered or reduced consciousness levels to emergency departments. By using EEG monitoring, subclinical seizure activity may be detected, leading to earlier pharmacological intervention and improved outcomes. Post-ictal phases that may be interpreted as seizure activity may become less over-treated. A feasibility study will ascertain if EEG monitoring can be applied successfully in this cohort, within a specified time period, obtaining minimum artefact (defined as \< 25% artefact). EEG recordings will not be used to guide clinical management during this feasibility study.

Read the detailed description

See study protocol attached

02

Conditions studied

  • Status Epilepticus
  • Altered Level of Consciousness
  • Non-epileptic Seizures
  • Epilepsy
  • Encephalopathy

Keywords

  • EEG
  • Emergency Department
  • Paediatrics
  • Reduced Glasgow Coma Scale (GCS)
03

In context

Seizures

881 studies on the registry are indexed under Seizures; 143 are open to participants now.

This study's enrollment of 20 is below the median of 150 across 235 observational studies indexed under Seizures.

Browse Seizures studies →

Lead sponsor

University College Cork is the lead sponsor of 116 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Months to 176 Months
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study population is all children between 0 years and 15 years and 11 months who present to the Resuscitation room of the Emergency Department of Cork University Hospital. Children can have underlying co-morbidities ( eg neurodisability, epilepsy) or be their first time presenting to a hospital.

Inclusion criteria

Children between 0 and 15 years and 11 months who present to Resuscitation Room, ED, CUH with a Glasgow Coma Scale (GCS) \< 11 or, a reduction in baseline GCS in the case of children with significant neurodisability at baseline

Exclusion criteria

Exclusion Criteria:

  • Polytrauma
  • Open head wounds
  • Unstable airway or requirement for bag and mask ventilation, where cap application would affect clinical management
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. The percentage of children who had EEG monitoring applied within twenty minutes and obtainment of an interpretable EEG recording with less than 25% artefact.

    Time frame: Anticipated 12 month study period

07

Study locations

1 site
  • Cork University Hospital (CUH)
    Cork, Munster T12 DC4A, Ireland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05259891
Lead sponsor
University College Cork
Responsible party
Dr. Deirdre Murray (Associate Professor and Consultant Paediatrician, Department of Paediatrics and Child Health and INFANT, UCC, Cork University Hospital, University College Cork) — Principal investigator
First posted
Mar 2, 2022
Start date
Jul 5, 2021
Primary completion
Jun 20, 2022
Completion
Jun 20, 2022
Last update
May 16, 2023

Study contacts

Deirdre Murray
principal investigator · UCC and INFANT Centre

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion